Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Raderer

Showing results (191-200 of 264) with videos related to

Pageof 27
Sort By:
BMC Cancer|June 30, 2021
A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trialAlexander Grunenberg, Lisa M Kaiser, Stephanie Woelfle, et al.
Haematologica|November 2, 2020
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatmentAnnarita Conconi, Catherine Thieblemont, Luciano Cascione, et al.
European Journal of Heart Failure|March 24, 2020
Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational studyMarkus S Anker, Maria K Frey, Georg Goliasch, et al.
European Journal of Clinical Investigation|June 4, 2021
Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centreChristoph Minichsdorfer, Georg Jeryczynski, Christoph Krall, et al.
Annals of Hematology|July 29, 2009
Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher ageDaniel Heintel, Cathrin Skrabs, Alexander Hauswirth, et al.
Clinical & Experimental Metastasis|December 8, 2023
Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care centerPetar Popov, Ariane Steindl, Ladislaia Wolff, et al.
Blood|January 9, 2003
High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphomaHongtao Ye, Hongxiang Liu, Markus Raderer, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicityNina Worel, Axel Schulenburg, Margit Mitterbauer, et al.
BMC Infectious Diseases|May 28, 2026
Real-world evidence from a tertiary academic center: clinical characteristics, microbiology and outcomes of oncology patients with febrile neutropenia presenting to the emergency departmentMarkus Kleinberger, Petar Popov, Anna Pfarrhofer, et al.
Theranostics|July 9, 2019
Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [<sup>68</sup>Ga]Ga-Pentixafor-PET/MRIAlexander R Haug, Asha Leisser, Wolfgang Wadsak, et al.
Pageof 27

Showing results (191-200 of 264) with videos related to

Sort By:
Pageof 27
BMC Cancer|June 30, 2021
A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trialAlexander Grunenberg, Lisa M Kaiser, Stephanie Woelfle, et al.
Haematologica|November 2, 2020
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatmentAnnarita Conconi, Catherine Thieblemont, Luciano Cascione, et al.
European Journal of Heart Failure|March 24, 2020
Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational studyMarkus S Anker, Maria K Frey, Georg Goliasch, et al.
European Journal of Clinical Investigation|June 4, 2021
Impact of COVID-19 lockdown on routine oncology versus emergency care at a high volume cancer centreChristoph Minichsdorfer, Georg Jeryczynski, Christoph Krall, et al.
Annals of Hematology|July 29, 2009
Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher ageDaniel Heintel, Cathrin Skrabs, Alexander Hauswirth, et al.
Clinical & Experimental Metastasis|December 8, 2023
Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care centerPetar Popov, Ariane Steindl, Ladislaia Wolff, et al.
Blood|January 9, 2003
High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphomaHongtao Ye, Hongxiang Liu, Markus Raderer, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicityNina Worel, Axel Schulenburg, Margit Mitterbauer, et al.
BMC Infectious Diseases|May 28, 2026
Real-world evidence from a tertiary academic center: clinical characteristics, microbiology and outcomes of oncology patients with febrile neutropenia presenting to the emergency departmentMarkus Kleinberger, Petar Popov, Anna Pfarrhofer, et al.
Theranostics|July 9, 2019
Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [<sup>68</sup>Ga]Ga-Pentixafor-PET/MRIAlexander R Haug, Asha Leisser, Wolfgang Wadsak, et al.
Pageof 27